Home  »  Company News   »  Arcadia Biosciences Inc. (RKDA) poses a Brand-New ...

Arcadia Biosciences Inc. (RKDA) poses a Brand-New Opportunity for Investors with beta value of -0.69

Arcadia Biosciences Inc. (RKDA) poses a Brand-New Opportunity for Investors with beta value of -0.69

Witnessing the stock’s movement on the chart, on June 09, 2021, Arcadia Biosciences Inc. (NASDAQ: RKDA) set off with pace as it heaved 3.78% to $3.02. During the day, the stock rose to $3.21 and sunk to $2.943 before settling in for the price of $2.91 at the close. Taking a more long-term approach, RKDA posted a 52-week range of $2.26-$6.40.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

It was noted that the giant of the Basic Materials sector posted annual sales growth of 8.20% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 45.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 89.70%. This publicly-traded company’s shares outstanding now amounts to $21.34 million, simultaneously with a float of $19.53 million. The organization now has a market capitalization sitting at $65.62 million. At the time of writing, stock’s 50-day Moving Average stood at $2.66, while the 200-day Moving Average is $2.96.

It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 58 workers. It has generated 138,517 per worker during the last fiscal year. Meanwhile, its income per employee was -80,259. The stock had 8.00 Receivables turnover and 0.20 Total Asset turnover. For the Profitability, stocks gross margin was +35.29, operating margin was -267.92 and Pretax Margin of -76.55.

Arcadia Biosciences Inc. (RKDA) Ownership Facts and Figures

Nothing is more important than checking the behaviour of major investors towards the stock of the Agricultural Inputs industry. Arcadia Biosciences Inc.’s current insider ownership accounts for 8.49%, in contrast to 8.40% institutional ownership. According to the most recent insider trade that took place on Aug 03, this organization’s Chief Executive Officer bought 585 shares at the rate of 3.16, making the entire transaction reach 1,849 in total value, affecting insider ownership by 14,285. Preceding that transaction, on Aug 03, Company’s Chief Technology Officer bought 700 for 3.16, making the whole transaction’s value amount to 2,212. This particular insider is now the holder of 13,000 in total.

Arcadia Biosciences Inc. (RKDA) Earnings and Revenue Records

As on 3/30/2021, Multinational firm has announced its last quarter scores, in which it reported $0.12 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.34) by $0.46. This company achieved a net margin of -57.94 while generating a return on equity of -26.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.

Arcadia Biosciences Inc.’s EPS increase for this current 12-month fiscal period is 89.70% and is forecasted to reach -0.77 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 14.96% through the next 5 years, which can be compared against the 45.10% growth it accomplished over the previous five years trading on the market.

Arcadia Biosciences Inc. (NASDAQ: RKDA) Trading Performance Indicators

Let’s observe the current performance indicators for Arcadia Biosciences Inc. (RKDA). It’s Quick Ratio in the last reported quarter now stands at 9.60. The Stock has managed to achieve an average true range (ATR) of 0.19. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 7.63.


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



In the same vein, RKDA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.73, a figure that is expected to reach -0.26 in the next quarter, and analysts are predicting that it will be -0.77 at the market close of one year from today.

Technical Analysis of Arcadia Biosciences Inc. (RKDA)

Going through the that latest performance of [Arcadia Biosciences Inc., RKDA]. Its last 5-days volume of 0.72 million was inferior to the volume of 2.18 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 69.03% While, its Average True Range was 0.20.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Raw Stochastic average of Arcadia Biosciences Inc. (RKDA) in the period of the previous 100 days is set at 18.36%, which indicates a major fall in contrast to 67.70% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 39.37% that was lower than 113.70% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

Sign up for Our Newsletter Now! Discover which stocks to trade!
100% Free. Stop Anytime. No Spam